Human Longevity has announced that it has appointed Scott Sorensen as its Chief Technology Officer. Sorenson previously worked at Ancestry, where he served in multiple roles including director of engineering and culminating as CTO. In the 16 past years at Ancestry, Sorenson directed the development of scalable technology platforms and architecture in addition to creating processes for engineers and scientists to deliver solutions to clients effectively.
Exact Sciences has appointed Mark Stenhouse to the new role of president for its flagship product Cologuard, a non-invasive stool-based DNA test for early detection of colorectal cancer. Stenhouse, who is currently serving as vice president of the US immunology group at AbbVie, will assume this new position on April 2. At AbbVie, Stenhouse leads the sales and marketing teams for the anti-inflammatory drug Humira. He has spent nearly 30 years at Abbott Laboratories/AbbVie, where he was first hired for a field sales position. He became national sales director in the US immunology-gastroenterology franchise, and rose to marketing director, followed by senior director of commercial initiatives. In 2010, Stenhouse was appointed a general manager within the company before being promoted to vice president.
George Cardoza, Sharon Virag
NeoGenomics announced the appointments of George Cardoza as president of the Pharma Services Division, and Sharon Virag as chief financial officer. The position of president of the Pharma Services Division is a newly created position. Cardoza, who has served as chief financial officer since 2009, will lead a division that grew revenues 69 percent to $8.7 million last year. The division also includes a new lab in Rolle, Switzerland that was added last year to meet Pharma Services demand. Virag, who is succeeding Cardoza in the chief financial officer role, was previously vice president, corporate finance and chief accounting officer, at Aetna. Her appointment is effective March 27.
For more recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.